PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-11.03%
Both yoy net incomes decline, with MCHP at -24.43%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
1.59%
Some D&A expansion while MCHP is negative at -3.74%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
90.54%
Well above MCHP's 42.08% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
-49.01%
Both reduce yoy usage, with MCHP at -232.18%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-100.00%
AR is negative yoy while MCHP is 100.00%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
54.37%
Inventory growth well above MCHP's 73.72%. Michael Burry would suspect potential future write-down risk if demand does not materialize.
100.00%
A yoy AP increase while MCHP is negative at -100.00%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
-10033.33%
Both reduce yoy usage, with MCHP at -200.52%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
400.00%
Well above MCHP's 355.50%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-19.03%
Both yoy CFO lines are negative, with MCHP at -14.04%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-23.29%
Negative yoy CapEx while MCHP is 53.77%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
99.18%
Purchases well above MCHP's 25.21%. Michael Burry would see major cash outflow into securities vs. competitor’s approach, risking near-term FCF.
-88.60%
We reduce yoy sales while MCHP is 8.50%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
No Data
No Data available this quarter, please select a different quarter.
-146.29%
We reduce yoy invests while MCHP stands at 202.95%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
17.11%
We slightly raise equity while MCHP is negative at -26.37%. John Neff sees competitor possibly preserving share count or buying back shares.
50.46%
Buyback growth of 50.46% while MCHP is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.